Cancer Education and Research Institute
United Nations, UNIATF Award 2019 Recipient

DONATE to support our programs
  • Home
    • About us >
      • About the Founder
    • Annual Reports and Media Kit
    • News Room >
      • Press Releases 2020
      • Press Releases 2019
      • Press Releases 2018
      • Press Releases 2017
      • Press Releases 2016
      • Press Releases 2015
      • Press Releases 2014
      • Press Releases 2013
    • Testimonials
  • TURKCE
    • Kanser videolarimizi izle
    • Kanser makalelerimiz
    • JSCR-Turkce
    • CERI Kisisellestirilmis Hasta Programi
    • Bağış Yap
  • Deutsch
    • Lernen Sie die Gründerin kennen
    • Unsere Krebs Videos ansehen
    • Unsere Krebs Artikel lesen
    • JSCR-Deutsch
    • Unsere Publikationen
    • CERI Personalisierter Patientenprogramm
  • MULTI-LANGUAGE CANCER BLOG
  • Patient Education
    • All about cancer
    • Watch Our Cancer Videos >
      • Ovarian cancer diagnosis
    • Our Publications >
      • Read CERI Simplified Cancer Research Articles
    • Cancer Types-Education
    • Cancer detection and cancer treatment
    • Cancer Awareness Months
    • CERI Personalized Patient Program
  • Events
  • Donate
    • Sponsorship levels
    • Membership
    • Become A Sponsor
    • Shop at CERI
    • Volunteer
    • Become a CERI Board Member
  • Contact us

What is OVARIAN CANCER? Must Watch! | By Cancer Education and Research Institute (CERI)

What is OVARIAN CANCER? | By Cancer Education and Research Institute (CERI)​
Ovarian cancer and cervical cancer is often confused with each other. In this episode we explain the differences between ovarian cancer and cervical cancer, ovarian cancer facts, symptoms, diagnosis, stages, and treatment. 
Please comment below and let us know your thoughts or questions. 

We also recently released our video, in which we explain the newly approved drug, Rubraca (rucaparib), by the FDA for advanced ovarian cancer patients whose tumors have BRCA gene mutation (abnormality). The FDA further approved FoundationFocus CDxBRCA companion diagnostic test for use with Rubraca, which is the first next-generation-sequencing (NGS)-based companion diagnostic approved by the FDA. This test detects the presence of deleterious BRCA gene abnormalities in the tumor tissue of ovarian cancer patients. https://www.youtube.com/watch?v=ojkAqwfmAF0
Read more on our blog on our website: https://www.canceredinstitute.org/cancer-blog-english/-fda-approves-new-treatment-for-advanced-ovarian-cancer

Watch our ovarian cancer series: 
Episode #18: Ovarian cancer intro
Episode #19: Ovarian cancer facts
Episode #20: Ovarian cancer symptoms
Episode #21: Ovarian cancer diagnosis
Episode #22: Ovarian cancer stages
Episode #23: Ovarian cancer treatment



Disclaimer: We can not assume responsibility of misinterpretation of content.

    Help us to serve you better!

Submit
Cancer Education and Research Institute® (formerly Cancer Research Simplified) is an independent 501(c)(3) non-proft organization.
Homepage 
Türkçe
Deutsch

About us
Meet the Founder
Meet the Team

News Room
Media Kit
Press Releases 
Watch Cancer Videos
Kanser videolarını izle
Krebs Videos ansehen
Cancer Resources

CERI Youth Program

Events

Shop at CERI


Ways to Help
Donate
Volunteer
Become A Sponsor

Blog
Blog-Deutsch
Blog-Türkçe

Cancer Awareness Months



Stay Involved
Facebook
Twitter
Youtube
LinkedIn

Testimonials

Jobs

Contact Us
Cancer Research Simplified Homepage
Terms of Service
Privacy Policy
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Copyright © 2013-2020 Cancer Education and Research Institute®. All Rights Reserved.                                  
Powered by Cancer Education and Research Institute®